Can a MR Imaging Scanner Accurately Measure Hematocrit to Determine ECV Fraction?

JACC: Cardiovascular Imaging

Volumn 9, Issue 1, 2016, Pages 64-66

  Bluemke, David A ^a   Kawel Boehm, Nadine ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

collagen; ECV; magnetic resonance imaging; mortality; myocardial fibrosis

Indexed keywords

GADOLINIUM; CONTRAST MEDIUM;

CARDIOMYOPATHY; EXTRACELLULAR SPACE; FIBROSIS; HEART MUSCLE; HEMATOCRIT; HUMAN; IMAGE ANALYSIS; NOTE; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; CARDIAC MUSCLE; CINE MAGNETIC RESONANCE IMAGING; DIAGNOSTIC IMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING;

CONTRAST MEDIA; DIAGNOSTIC IMAGING; FIBROSIS; HEMATOCRIT; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE IMAGING, CINE; MYOCARDIUM;

EID: 84952933959     PISSN: 1936878X     EISSN: 18767591     Source Type: Journal    
DOI: 10.1016/j.jcmg.2015.11.009     Document Type: Editorial

References (20)

1. N. Mewton, C.Y. Liu, P. Croisille, D. Bluemke, and J.A. Lima Assessment of myocardial fibrosis with cardiovascular magnetic resonance J Am Coll Cardiol 57 2011 891 903
2. N. Kawel-Boehm, A. Maceira, E.R. Valsangiacomo-Buechel, and et al. Normal values for cardiovascular magnetic resonance in adults and children J Cardiovasc Magn Reson 17 2015 29
3. M. Barth, and E. Moser Proton NMR relaxation times of human blood samples at 1.5 T and implications for functional MRI Cell Mol Biol (Noisy-le-grand) 43 1997 783 791
4. V.O. Puntmann, T. Voigt, Z. Chen, and et al. Native T1 mapping in differentiation of normal myocardium from diffuse disease in hypertrophic and dilated cardiomyopathy J Am Coll Cardiol Img 6 2013 475 484
5. S. Pica, D.M. Sado, V. Maestrini, and et al. Reproducibility of native myocardial T1 mapping in the assessment of Fabry disease and its role in early detection of cardiac involvement by cardiovascular magnetic resonance J Cardiovasc Magn Reson 16 2014 99
6. T.D. Karamitsos, S.K. Piechnik, S.M. Banypersad, and et al. Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis J Am Coll Cardiol Img 6 2013 488 497
7. A.S. Flett, M.P. Hayward, M.T. Ashworth, and et al. Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans Circulation 122 2010 138 144
8. D.R. Messroghli, S. Nordmeyer, T. Dietrich, and et al. Assessment of diffuse myocardial fibrosis in rats using small-animal Look-Locker inversion recovery T1 mapping Circ Cardiovasc Imaging 4 2011 636 640
9. N. Kawel, E.B. Turkbey, J.J. Carr, and et al. Normal left ventricular myocardial thickness for middle-aged and older subjects with steady-state free precession cardiac magnetic resonance: the multi-ethnic study of atherosclerosis Circ Cardiovasc Imaging 5 2012 500 508
10. D.M. Sado, A.S. Flett, S.M. Banypersad, and et al. Cardiovascular magnetic resonance measurement of myocardial extracellular volume in health and disease Heart 98 2012 1436 1441
11. C.Y. Ho, S.A. Abbasi, T.G. Neilan, and et al. T1 measurements identify extracellular volume expansion in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy Circ Cardiovasc Imaging 6 2013 415 422
12. T.G. Neilan, O.R. Coelho-Filho, R.V. Shah, and et al. Myocardial extracellular volume by cardiac magnetic resonance imaging in patients treated with anthracycline-based chemotherapy Am J Cardiol 111 2013 717 722
13. T.C. Wong, K. Piehler, C.G. Meier, and et al. Association between extracellular matrix expansion quantified by cardiovascular magnetic resonance and short-term mortality Circulation 126 2012 1206 1216
14. S. Liu, J. Han, M.S. Nacif, and et al. Diffuse myocardial fibrosis evaluation using cardiac magnetic resonance T1 mapping: sample size considerations for clinical trials J Cardiovasc Magn Reson 14 2012 90
15. J.C. Moon, D.R. Messroghli, P. Kellman, and et al. Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement J Cardiovasc Magn Reson 15 2013 92
16. T.A. Treibel, M. Fontana, V. Maestrini, and et al. Automatic measurement of the myocardial interstitium: synthetic extracellular volume quantification without hematocrit sampling J Am Coll Cardiol Img 9 2016 54 63
17. H. Lu, C. Clingman, X. Golay, and P.C. van Zijl Determining the longitudinal relaxation time (T1) of blood at 3.0 Tesla Magn Reson Med 52 2004 679 682
18. R.A. Stott, G.L. Hortin, T.R. Wilhite, S.B. Miller, C.H. Smith, and M. Landt Analytical artifacts in hematocrit measurements by whole-blood chemistry analyzers Clin Chem 41 1995 306 311
19. W. Schmidt, B. Biermann, P. Winchenbach, S. Lison, and D. Boning How valid is the determination of hematocrit values to detect blood manipulations? Int J Sports Med 21 2000 133 138
20. G.A. Mayer Diurnal, postural and postprandial variations of hematocrit Can Med Assoc J 93 1965 1006 1008